However, elevated levels of betaglycan have also been reported in colon, triple-negative breast cancers and lymphomas, with a role in promoting bone metastasis in prostate cancer [56], indicating contextual roles for betaglycan in tumor progression [48, 57, 58]. Here, TGFBR3 is linked to prostate cancer.